MARKETS

BSE Prices delayed by 5 minutes... Prices as on Apr 25, 2019 - 4:03PM   ABB India 1499.85 [ 1.04% ]ACC 1622.1 [ 0.95% ]Ambuja Cements Ltd. 220.65 [ -1.67% ]Asian Paints Ltd. 1446 [ -0.22% ]Axis Bank Ltd. 744.45 [ -1.08% ]Bajaj Auto Ltd. 3088.8 [ 0.41% ]Bank of Baroda 122.15 [ -2.36% ]Bharti Airtel 331.25 [ 2.08% ]Bharat Heavy Ele 72.15 [ -1.77% ]Bharat Petroleum 359 [ 3.01% ]Britannia Ind. 2971.4 [ -0.16% ]Cairn India Ltd. 285.4 [ 0.90% ]Cipla 559.9 [ 0.02% ]Coal India 250.8 [ -1.34% ]Colgate Palm. 1203 [ -0.98% ]Dabur India 396.9 [ -0.46% ]DLF Ltd. 175.35 [ -0.48% ]Dr. Reddy's Labs 2930 [ 2.61% ]GAIL (India) Ltd. 343.9 [ -0.48% ]Grasim Inds. 921.5 [ 4.60% ]HCL Technologies 1133.6 [ -0.60% ]HDFC 1957.8 [ -1.08% ]HDFC Bank 2262.9 [ -0.73% ]Hero MotoCorp 2606.1 [ -0.64% ]Hindustan Unilever L 1731.2 [ -1.23% ]Hindalco Indus. 197 [ -1.94% ]ICICI Bank 397 [ -1.01% ]IDFC L 43 [ 1.65% ]Indian Hotels Co 152 [ -0.23% ]IndusInd Bank 1679.9 [ -1.19% ]Infosys 731.2 [ -0.71% ]ITC Ltd. 306.05 [ -0.13% ]Jindal St & Pwr 167.6 [ -2.64% ]Kotak Mahindra Bank 1359.2 [ -0.79% ]L&T 1355 [ -0.39% ]Lupin Ltd. 870.9 [ 0.74% ]Mahi. & Mahi 662 [ -0.90% ]Maruti Suzuki India 6868.05 [ -2.23% ]MTNL 12.54 [ 1.29% ]Nestle India 10879 [ 0.43% ]NIIT Ltd. 110.15 [ -1.39% ]NMDC Ltd. 100.35 [ -2.00% ]NTPC 133.2 [ -0.45% ]ONGC 168.6 [ -0.06% ]Punj. NationlBak 86.6 [ -2.04% ]Power Grid Corpo 191.4 [ -0.29% ]Reliance Inds. 1372.95 [ -1.23% ]SBI 306.45 [ -1.37% ]Vedanta 170.9 [ -2.26% ]Shipping Corpn. 35.35 [ 1.14% ]Sun Pharma. 463 [ -1.31% ]Tata Chemicals 573 [ -1.60% ]Tata Global Beverage 211.5 [ 1.24% ]Tata Motors Ltd. 220.7 [ -1.34% ]Tata Steel 510.1 [ -2.89% ]Tata Power Co. 67.75 [ 0.00% ]Tata Consultancy 2197.2 [ 0.54% ]Tech Mahindra Ltd. 815 [ -0.44% ]UltraTech Cement 4622.3 [ 5.14% ]United Spirits 549.85 [ -0.87% ]Wipro Ltd 294.25 [ 0.39% ]Zee Entertainment En 416.9 [ -0.25% ]

News Details

You can view in detail.
Glenmark Pharmaceuticals gets ANDA nod for Sevelamer Hydrochloride tablets 11/02/2019 11:59

Drug maker Glenmark Pharmaceuticals Inc., USA (Glenmark) on Monday said that, “it has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Sevelamer Hydrochloride Tablets, 400 mg and 800 mg, a generic version of Renagel®1 Tablets, 400 mg and 800 mg, of Genzyme Corporation,” in a filing to Bombay Stock Exchange.

According to IQVIATM sales data for the 12 month period ending December 2018, the Renagel® Tablets, 400 mg and 800 mg market2 achieved annual sales of approximately $102.1 million.

“Glenmark’s current portfolio consists of 149 products authorized for distribution in the U.S. marketplace and 53 ANDA’s pending approval with the U.S. FDA,” the company said.

In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

The shares of the company were trading at 605.00 apiece, low at 9.45 points or 1.54 per cent at 11:55 hours on the BSE.

LOAD MORE